|
1
|
Karpathiou G, Dumollard JM, Dridi M, Dal
Col P, Barral FG, Boutonnat J and Peoc'h M: Chordomas: A review
with emphasis on their pathophysiology, pathology, molecular
biology, and genetics. Pathol Res Pract. 216:1530892020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Couce ME, Aker FV and Scheithauer BW:
Chordoid meningioma: A clinicopathologic study of 42 cases. Am J
Surg Pathol. 24:899–905. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Nambiar A, Pillai A, Parmar C and Panikar
D: Intraventricular chordoid meningioma in a child: Fever of
unknown origin, clinical course, and response to treatment. J
Neurosurg Pediatr. 10:478–481. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Oakley GJ, Fuhrer K and Seethala RR:
Brachyury, SOX-9, and podoplanin, new markers in the skull base
chordoma vs chondrosarcoma differential: A tissue microarray-based
comparative analysis. Mod Pathol. 21:1461–1469. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Medical Research Council: Nerve Injuries
Committee, . M.R.C. War Memorandum: Aids to the investigation of
peripheral nerve injuries. Physical Therapy. 23:1401943. View Article : Google Scholar
|
|
6
|
Louis DN, Perry A, Wesseling P, Brat DJ,
Cree IA, Figarella-Branger D, Hawkins C, Ng HK, Pfister SM,
Reifenberger G, et al: The 2021 WHO classification of tumors of the
central nervous system: A summary. Neuro Oncol. 23:1231–1251. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Choi JH and Ro JY: The 2020 WHO
classification of tumors of soft tissue: Selected changes and new
entities. Adv Anat Pathol. 28:44–58. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lin JW, Ho JT, Lin YJ and Wu YT: Chordoid
meningioma: A clinicopathologic study of 11 cases at a single
institution. J Neurooncol. 100:465–473. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Santegoeds RGC, Temel Y,
Beckervordersandforth JC, Van Overbeeke JJ and Hoeberigs CM:
State-of-the-art imaging in human chordoma of the skull base. Curr
Radiol Rep. 6:162018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Golden L, Pendharkar A and Fischbein NJc:
Chapter 7 - Imaging Cranial Base Chordoma and Chondrosarcoma.
Chordomas and Chondrosarcomas of the Skull Base and Spine. 2nd
Edition. Elsevier Inc.; pp. 67–78. 2018, View Article : Google Scholar
|
|
11
|
Farsad K, Kattapuram SV, Sacknoff R, Ono J
and Nielsen GP: Sacral chordoma. Radiographics. 29:1525–1530. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Loken EK and Huang RY: Advanced meningioma
imaging. Neurosurg Clin N Am. 34:335–345. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sangoi AR, Dulai MS, Beck AH, Brat DJ and
Vogel H: Distinguishing chordoid meningiomas from their histologic
mimics: An immunohistochemical evaluation. Am J Surg Pathol.
33:669–681. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lehtonen E, Stefanovic V and Saraga-Babic
M: Changes in the expression of intermediate filaments and
desmoplakins during development of human notochord.
Differentiation. 59:43–49. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Folpe AL, Agoff SN, Willis J and Weiss SW:
Parachordoma is immunohistochemically and cytogenetically distinct
from axial chordoma and extraskeletal myxoid chondrosarcoma. Am J
Surg Pathol. 23:1059–1067. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Vujovic S, Henderson S, Presneau N, Odell
E, Jacques TS, Tirabosco R, Boshoff C and Flanagan AM: Brachyury, a
crucial regulator of notochordal development, is a novel biomarker
for chordomas. J Pathol. 209:157–165. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dridi M, Boutonnat J, Dumollard JM, Peoc'h
M and Karpathiou G: Patterns of brachyury expression in chordomas.
Ann Diagn Pathol. 53:1517602021. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Miettinen M, Wang Z, Lasota J, Heery C,
Schlom J and Palena C: Nuclear brachyury expression is consistent
in chordoma, common in germ cell tumors and small cell carcinomas,
and rare in other carcinomas and sarcomas: An immunohistochemical
study of 5229 cases. Am J Surg Pathol. 39:1305–1312. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Scheil S, Brüderlein S, Liehr T, Starke H,
Herms J, Schulte M and Möller P: Genome-wide analysis of sixteen
chordomas by comparative genomic hybridization and cytogenetics of
the first human chordoma cell line, U-CH1. Genes Chromosomes
Cancer. 32:203–211. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hallor KH, Staaf J, Jönsson G, Heidenblad
M, Vult von Steyern F, Bauer HC, Ijszenga M, Hogendoorn PC, Mandahl
N, Szuhai K and Mertens F: Frequent deletion of the CDKN2A locus in
chordoma: Analysis of chromosomal imbalances using array
comparative genomic hybridisation. Br J Cancer. 98:434–442. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kuźniacka A, Mertens F, Strömbeck B,
Wiegant J and Mandahl N: Combined binary ratio labeling
fluorescence in situ hybridization analysis of chordoma. Cancer
Genet Cytogenet. 151:178–181. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Roberts CW and Biegel JA: The role of
SMARCB1/INI1 in development of rhabdoid tumor. Cancer Biol Ther.
8:412–416. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kim KH and Roberts CWM: Targeting EZH2 in
cancer. Nat Med. 22:128–134. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Horbinski C, Oakley GJ, Cieply K, Mantha
GS, Nikiforova MN, Dacic S and Seethala RR: The prognostic value of
Ki-67, p53, epidermal growth factor receptor, 1p36, 9p21, 10q23,
and 17p13 in skull base chordomas. Arch Pathol Lab Med.
134:1170–1176. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wei J, Wu J, Yin Z, Li X, Liu Y, Wang Y,
Wang Z, Xu C and Fan L: Low expression of H3K27me3 is associated
with poor prognosis in conventional chordoma. Front Oncol.
12:10484822022. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Margueron R and Reinberg D: The polycomb
complex PRC2 and its mark in life. Nature. 469:343–349. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Karele EN and Paze AN: Chordoma: To know
means to recognize. Biochim Biophys Acta Rev Cancer.
1877:1887962022. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Heery CR, Palena C, McMahon S, Donahue RN,
Lepone LM, Grenga I, Dirmeier U, Cordes L, Marté J, Dahut W, et al:
Phase I study of a poxviral TRICOM-based vaccine directed against
the transcription factor brachyury. Clin Cancer Res. 23:6833–6845.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yurter A, Sciubba D, Gokaslan Z and
Kaloostian PJJN: Spinal Chordomas: Current Medical and Surgical
Management: JSM Neurosurgery and Spine. 2014.
|
|
30
|
Pan Y, Lu L, Chen J, Zhong Y and Dai Z:
Analysis of prognostic factors for survival in patients with
primary spinal chordoma using the SEER Registry from 1973 to 2014.
J Orthop Surg Res. 13:762018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Daoud EV, Zhu K, Mickey B, Mohamed H, Wen
M, Delorenzo M, Tran I, Serrano J, Hatanpaa KJ, Raisanen JM, et al:
Epigenetic and genomic profiling of chordoid meningioma:
Implications for clinical management. Acta Neuropathol Commun.
10:562022. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tahta A, Genc B, Cakir A and Sekerci Z:
Chordoid meningioma: Report of 5 cases and review of the
literature. Br J Neurosurg. 37:41–44. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ren L, Hua L, Deng J, Cheng H, Wang D,
Chen J, Xie Q, Wakimoto H and Gong Y: Favorable long-term outcomes
of chordoid meningioma compared with the other WHO grade 2
meningioma subtypes. Neurosurgery. 92:745–755. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Rekhi B and Karmarkar S:
Clinicocytopathological spectrum, including uncommon forms, of nine
cases of chordomas with immunohistochemical results, including
brachyury immunostaining: A single institutional experience.
Cytopathology. 30:229–235. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Murali R and Ng T: Chordoid meningioma
masquerading as chordoma. Pathology. 36:198–201. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Presneau N, Shalaby A, Ye H, Pillay N,
Halai D, Idowu B, Tirabosco R, Whitwell D, Jacques TS, Kindblom LG,
et al: Role of the transcription factor T (brachyury) in the
pathogenesis of sporadic chordoma: A genetic and functional-based
study. J Pathol. 223:327–335. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Goode B, Mondal G, Hyun M, et al: A
recurrent kinase domain mutation in PRKCA defines chordoid glioma
of the third ventricle. Nat Commuml. 9:8102018. View Article : Google Scholar
|
|
38
|
Reifenberger G, Weber T, Weber RG, Wolter
M, Brandis A, Kuchelmeister K, Pilz P, Reusche E, Lichter P and
Wiestler OD: Chordoid glioma of the third ventricle:
Immunohistochemical and molecular genetic characterization of a
novel tumor entity. Brain Pathol. 9:617–626. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ogura K, Fujiwara T, Beppu Y, Chuman H,
Yoshida A, Kawano H and Kawai A: Extraskeletal myxoid
chondrosarcoma: A review of 23 patients treated at a single
referral center with long-term follow-up. Arch Orthop Trauma Surg.
132:1379–1386. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Flucke U, Tops BBJ, Verdijk MAJ, van Cleef
PJH, van Zwam PH, Slootweg PJ, Bovée JVMG, Riedl RG, Creytens DH,
Suurmeijer AJH and Mentzel T: NR4A3 rearrangement reliably
distinguishes between the clinicopathologically overlapping
entities myoepithelial carcinoma of soft tissue and cellular
extraskeletal myxoid chondrosarcoma. Virchows Archiv. 460:621–628.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Amary MF, Bacsi K, Maggiani F, Damato S,
Halai D, Berisha F, Pollock R, O'Donnell P, Grigoriadis A, Diss T,
et al: IDH1 and IDH2 mutations are frequent events in central
chondrosarcoma and central and periosteal chondromas but not in
other mesenchymal tumours. J Pathol. 224:334–343. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Pansuriya TC, van Eijk R, d'Adamo P, van
Ruler MAJH, Kuijjer ML, Oosting J, Cleton-Jansen AM, van Oosterwijk
JG, Verbeke SLJ, Meijer D, et al: Somatic mosaic IDH1 and IDH2
mutations are associated with enchondroma and spindle cell
hemangioma in Ollier disease and Maffucci syndrome. Nat Genet.
43:1256–1261. 2011. View Article : Google Scholar : PubMed/NCBI
|
